SynthesisJournal of robotic surgery2025
Robot-assisted partial nephrectomy for technically challenging renal tumors (completely endophytic and hilar): a systematic review and meta-analysis of perioperative, oncological, and functional outcomes.
Synthesis in Journal of robotic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- On-Clamp Versus Off-Clamp Robot-Assisted Partial Nephrectomy for Localized Renal Tumors: A Retrospective Single-Center Cohort Study.Diagnostics (Basel, Switzerland) · 2026Article
- Optimizing outcomes of partial nephrectomy in patients with tumors in solitary kidneys: a non-systematic review.Journal of medicine and life · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Robot-assisted partial nephrectomy (RAPN) has emerged as a surgical option for renal tumors. This study aimed to compare perioperative, functional, and oncological outcomes of RAPN between completely endophytic and hilar renal tumors versus non-completely endophytic and non-hilar tumors. Following PRISMA guidelines, we conducted a comprehensive search of PubMed, Embase, Web of Science, and Cochrane Library databases. We included studies comparing outcomes between completely endophytic and hilar tumors versus non-completely endophytic and non-hilar tumors treated with RAPN. The study protocol was registered with PROSPERO (ID: CRD42024628029). The analysis included thirteen studies with 8572 patients. Compared to non-completely endophytic and non-hilar tumors, the complex tumor group demonstrated significantly increased operative time (Mean Difference [MD]: 13.79 min; 95% CI: 5.12-22.45; p = 0.002), higher blood loss (MD: 23.73 mL; 95% CI: 4.15-43.30; p = 0.02), greater decline in estimated glomerular filtration rate (eGFR) (MD: 2.19 ml/min/1.73 m
Indexed as
Identifiers
40208473What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.